Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 163 (RN7SKP163) is a pseudogene related to the 7SK small nuclear RNA gene (RN7SK). Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations or deletions that prevent their transcription or translation into functional products. RN7SKP163 is catalogued in gene registries but is not expressed as a functional RNA or protein, and thus does not play a direct biological, disease, or pharmacological role[3][5]. For actual functional and disease-related information, the biologically active RNA is RN7SK (not the pseudogene), which regulates transcription elongation, cell proliferation, and macrophage immune functions, but this does not pertain to RN7SKP163 [1][6][7][2][4]. RN7SKP163 (RN7SK pseudogene 163) is a non-functional genomic locus. It is not a receptor, enzyme, transporter, or drug target. It does not have disease relevance, interacting drugs, or therapeutic mechanism. Confusion can result from conflating the pseudogene with RN7SK, which is an actively studied noncoding RNA[3][5].
None (for the pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 163 (RN7SKP163).